🇺🇸 FDA
Pipeline program

Tradipitant

VP-VLY-686-3601

Phase 3 small_molecule active

Quick answer

Tradipitant for Nausea and Vomiting is a Phase 3 program (small_molecule) at Vanda Pharmaceuticals with 1 ClinicalTrials.gov record(s).

Program details

Company
Vanda Pharmaceuticals
Indication
Nausea and Vomiting
Phase
Phase 3
Modality
small_molecule
Status
active

Clinical trials